RxDoctor Payments Data
★ My doctorsLook up a doctor →

Mark Sedlak

Psychiatric/Mental Health · Hazlet, NJNPI 1710522768

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 41.6% of the total. Reporting peaked in 2024 at $474 and has fallen 64.3% since, to $169 in 2025.

$1,314in general payments, 2019–2025

Across 113 payments — averaging $11.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$546
  • Supernus Pharmaceuticals, Inc.$156
  • Axsome Therapeutics, Inc.$117
  • Corium, LLC$88
  • Ironshore Pharmaceuticals Inc.$68
  • Collegium Pharmaceutical, Inc.$64
  • plus $275 from 11 others

What the payments were for

  • Food & beverage$1,314100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie60$546
Supernus Pharmaceuticals, Inc.9$156
Axsome Therapeutics, Inc.7$117
Corium, LLC10$88
Ironshore Pharmaceuticals Inc.4$68
Collegium Pharmaceutical, Inc.4$64
Indivior Inc.4$51
Johnson & Johnson2$36
Alkermes, Inc.2$33
Teva Pharmaceuticals USA, Inc.2$28
Lundbeck LLC2$28
Neurocrine Biosciences, Inc.2$26
Otsuka America Pharmaceutical, Inc.1$17
Genentech USA, Inc.1$15
Neos Therapeutics, LP1$15
Bausch Health US, LLC1$14
Takeda Pharmaceuticals U.S.A., Inc.1$12

How this compares

$1,314 in reported general payments places this provider in the 70th percentile of 1,212 psychiatric/mental health providers in New Jersey.

See all psychiatric/mental health providers in New Jersey →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Risperidone19$205
Mirtazapine14$63
Fluoxetine Hcl11$18

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Hazlet

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →